Fig. 3
From: Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South Africa
30 day Wisepill® adherence in participants with viral breakthrough, according to resistance testing status: Viral breakthrough with resistance, viral breakthrough without resistance, viral breakthrough where genotyping was unsuccessful and viral breakthrough where genotyping was not performed. The graph is right justified, with time to first confirmed viral breakthrough in months, with month 0 at which viral breakthrough occurred